FT
PHAT icon

Fiduciary Trust’s Phathom Pharmaceuticals PHAT Stock Holding History

Fiduciary Trust’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$388K Buy
35,731
+17,664
+98% +$202K ﹤0.01% 670
2026
Q1 		$201K Buy
18,067
+2,027
+13% +$25.6K ﹤0.01% 850
2025
Q4 		$266K Sell
16,040
-75
-0.5% -$1.07K ﹤0.01% 754
2025
Q3 		$190K Buy
16,115
+5,210
+48% +$53.8K ﹤0.01% 830
2025
Q2 		$105K Hold
10,905
– – ﹤0.01% 818
2025
Q1 		$68.4K Buy
+10,905
New +$66.2K ﹤0.01% 812

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Fiduciary Trust's PHAT Position: Q2 2026 in Review

Fiduciary Trust increased its Phathom Pharmaceuticals (PHAT) stake by 98% in Q2 2026, buying an estimated $202K and bringing the position to 35,731 shares worth $388K. The position accounts for ﹤0.01% of the portfolio, ranked #670.

Fiduciary Trust first reported a position in PHAT in Q1 2025 and has held it in 6 quarters since. 162 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.

  • Fiduciary Trust held 35,731 shares of Phathom Pharmaceuticals worth $388K as of Q2 2026.
  • Fiduciary Trust bought 17,664 Phathom Pharmaceuticals shares in Q2 2026, an estimated $202K.
  • Phathom Pharmaceuticals made up ﹤0.01% of Fiduciary Trust's portfolio in Q2 2026, its #670 holding.
  • Fiduciary Trust first reported a position in Phathom Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 162 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.

Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.